Breast Cancer Clinical Trial
Official title:
Randomized Controlled Study Assessing the Feasibility and the Medico-economic Impact of Nutritional Intervention in Women With Breast Cancer Under Adjuvant Chemotherapy
Breast cancer is the most common cancer in women. Weight gain in adulthood, overweight or
obesity, physical inactivity and alcohol consumption are risk factors commonly associated
with risk of breast cancer (mainly for post-menopausal for overweight and obesity). Reduced
physical activity is one factor likely to weight gain in women after adjuvant chemotherapy
for localized breast cancer. Furthermore, physical activity appropriately could improve many
prognostic factors and survival of women after breast cancer. Adapted Physical Activity
(APA) could improve fitness, quality of life, body image, treatment compliance and reduce
fatigue.
After diagnosis of breast cancer, there is many possible risk factors of mortality or
morbidity related to nutritional factors available to management. These risks prevention
through management of these patients appears indispensable through an APA program.
Thus, the investigators propose to test the feasibility of implementing a program of dietary
intervention and APA to prevent the risk of weight gain (which affects more than half of
patients) and maintain and/or increase their level of physical activity during and after
adjuvant chemotherapy.
With approximately 52,600 new cases diagnosed in France in 2010, breast cancer is the most
common cancer in women, according to national projections of the incidence and cancer
mortality for 2010.
Weight gain in adulthood, overweight or obesity, physical inactivity and alcohol consumption
are risk factors commonly associated with risk of breast cancer (mainly for post-menopausal
for overweight and obesity).
Several hypotheses explain the association between obesity and breast cancer: obesity,
metabolic syndrome and diabetes participate to changes in hormone levels (estrogen, leptin,
insulin) that promotes mammary carcinogenesis and tumor progression.
The association between obesity and development of breast cancer is partly due to increased
serum levels of estradiol produced by adipocytes, but the role of insulin resistance and
inflammation associated with obesity is widely discussed.
Reduced physical activity is one factor likely to weight gain in women after adjuvant
chemotherapy for localized breast cancer. Furthermore, physical activity appropriately could
improve many prognostic factors and survival of women after breast cancer. Thus, several
large cohort studies of women with breast cancer showed an average mortality reduction of
45% associated with moderate physical activity compared with inactivity. Adapted Physical
Activity (APA) could also improve fitness, quality of life, body image, treatment compliance
and reduce fatigue.
A rich fruits and vegetables diet combined with regular physical activity appears to offer
the best protection from breast cancer. The nature, frequency, duration, intensity and
arrangement of physical training program meetings are key elements to consider, metabolic
responses differ according to these factors.
The optimal management for an improved level of physical activity appear to be an individual
of at least three sessions per week, 30 to 60 minutes each with a moderate intensity,
allowing a physiological response to chronic exercise and an adequate recovery.
After diagnosis of breast cancer, there is thus many possible risk factors of mortality or
morbidity related to nutritional factors available to management. These risks prevention
through management of these patients appears indispensable through an APA program.
Thus, the investigators propose to test the feasibility of implementing a program of dietary
intervention and APA to prevent the risk of weight gain (which affects more than half of
patients) and maintain and/or increase their level of physical activity during and after
adjuvant chemotherapy.
;
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
| Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
| Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
| Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
| Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
| Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
| Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
| Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
| Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
| Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
| Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
| Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
| Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
| Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
| Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
| Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
| Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
| Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A | |
| Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
| Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A |